Glucagon-like Peptide-1 Receptor Agonists and Lower Depression Risk in Older Adults with Diabetes
Click here to read the study in Annals of Internal Medicine ©2025 2 Minute Medicine, Inc. All rights ...
Tag: diabetes mellitus
Glucagon-like peptide-1 receptor agonists associated with lower depression risk in older adults with diabetes
1. In this target trial emulation, glucagon-like peptide-1 receptor agonists (GLP-1RAs) were associated with a lower risk of depression compared ...
Roux-en-Y gastric bypass and sleeve gastrectomy may be equally cost-effective among patients with type 2 diabetes
1. In this retrospective cohort study of patients with diabetes who received Roux-en-Y gastric bypass (RYGB) or sleeve gastrectomy, health ...
![Active smoking cessation intervention may provide tangible results [Project CLIQ]](https://www.2minutemedicine.com/wp-content/uploads/2014/12/smoking-e1418644951268-350x250.jpg)
Semaglutide may aid tobacco cessation in patients with comorbid diabetes
1. In this retrospective study of patients with comorbid type 2 diabetes mellitus and tobacco use disorder (TUD), semaglutide use ...
#VisualAbstract: Oral Glucose-Lowering Agents are Not Noninferior to Insulin for Gestational Diabetes
Click here to read this study in JAMA. ©2024 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced ...
Novo Nordisk’s Rybelsus demonstrates reduction in cardiovascular events for patients with Type 2 diabetes and cardiovascular disease
Rybelsus in combination with standard T2DM therapy reduced the risk of major cardiovascular events by 14% in patients with diabetes ...
The Scan by 2 Minute Medicine®: Versatile Ozempic, Healthcare Reform, Unlocking the Brain, and Chickens and the Next Pandemic:
The Scan by 2 Minute Medicine® is a pop-culture medical newsletter and exclusive benefit for 2 Minute Medicine Plus subscribers. We ...
![Type I diabetes not associated with early menopause [OVADIA study]](https://www.2minutemedicine.com/wp-content/uploads/2014/12/diabetes1_edited-350x250.jpg)
Risk factors for diabetes in people with HIV
1. This follow-up analysis of the phase 3 REPRIEVE trial demonstrated that region of residence, prediabetes, high BMI, and metabolic ...
Semaglutide reduces cardiovascular events in patients with atherosclerotic disease and obesity
1. Patients assigned to semaglutide reported reduced major adverse cardiovascular events, regardless of heart failure subtype. 2. Benefits were consistent ...
Early intensive glycemic control reduces long-term risk of death and myocardial infarction in patients with type 2 diabetes
1. Sulfonylurea, insulin therapy, and metformin resulted in a significant relative risk reduction for all-cause mortality and myocardial infarction. 2. ...